Efficacy and Safety of ALT-801 in the Treatment of Obesity
Public ClinicalTrials.gov record NCT05295875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled and Parallel Group 48-Week Study to Evaluate the Efficacy and Safety of ALT-801 in the Treatment of Obesity (MOMENTUM Trial)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the efficacy and safety of ALT-801 once-weekly versus placebo as an adjunct to a reduced-calorie diet and increased physical activity in patients with obesity/overweight.
Study identification
- NCT ID
- NCT05295875
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 391 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 30, 2022
- Primary completion
- Sep 27, 2023
- Completion
- Sep 27, 2023
- Last update posted
- Nov 28, 2023
2022 – 2023
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altimmune CTM | Birmingham | Alabama | 35020 | — |
| Altimmune CTM | Mesa | Arizona | 85201 | — |
| Altimmune CTM | Los Angeles | California | 90001 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Altimmune CTM | Montclair | California | 91763 | — |
| Altimmune CTM | Santa Barbara | California | 93101 | — |
| Altimmune CTM | Boca Raton | Florida | 33427 | — |
| Altimmune CTM | Clearwater | Florida | 33755 | — |
| Altimmune CTM | Fort Myers | Florida | 33900 | — |
| Altimmune CTM | Jacksonville | Florida | 32201 | — |
| Altimmune CTM | Port Orange | Florida | 32123 | — |
| Altimmune CTM | Sunrise | Florida | 33319 | — |
| Altimmune CTM | Savannah | Georgia | 31411 | — |
| Altimmune CTM | Evanston | Illinois | 60201 | — |
| Altimmune CTM | Indianapolis | Indiana | 46201 | — |
| Midwest Institute for Clinical Research | Indianapolis | Indiana | 46260 | — |
| Altimmune CTM | Louisville | Kentucky | 40202 | — |
| Altimmune CTM | Baton Rouge | Louisiana | 70801 | — |
| Altimmune CTM | New Orleans | Louisiana | 70119 | — |
| Altimmune CTM | Kansas City | Missouri | 64101 | — |
| Altimmune CTM | Butte | Montana | 59701 | — |
| Altimmune CTM | Berlin | New Jersey | 08009 | — |
| Altimmune CTM | New York | New York | 10001 | — |
| Cornell University, Joan and Sanford Weill Medical College | New York | New York | 10065 | — |
| Altimmune CTM | Cincinnati | Ohio | 45201 | — |
| Altimmune CTM | Philadelphia | Pennsylvania | 19092 | — |
| Altimmune CTM | Knoxville | Tennessee | 37901 | — |
| Altimmune CTM | Austin | Texas | 78701 | — |
| Altimmune CTM | Bellaire | Texas | 77401 | — |
| Altimmune CTM | San Antonio | Texas | 78201 | — |
| Altimmune CTM | St. George | Utah | 84770 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05295875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 28, 2023 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05295875 live on ClinicalTrials.gov.